Nevirapine/Batch
API
Summary
An ultra-efficient synthetic method has been developed for nevirapine drug substance which requires a single unit operation to convert starting materials into product in high yield (87% overall). The new process employs inexpensive raw materials and limited unit operations to produce an API that meets or exceeds all USP specifications.
